QGE031 + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Allergy
Conditions
Allergy
Trial Timeline
Mar 1, 2011 → Aug 1, 2012
NCT ID
NCT01596712About QGE031 + Placebo
QGE031 + Placebo is a phase 1 stage product being developed by Novartis for Allergy. The current trial status is completed. This product is registered under clinical trial identifier NCT01596712. Target conditions include Allergy.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01451450 | Phase 2 | Withdrawn |
| NCT02336425 | Phase 2 | Terminated |
| NCT01688882 | Phase 2 | Terminated |
| NCT01596712 | Phase 1 | Completed |
Competing Products
20 competing products in Allergy